CytoMed Therapeutics Ltd financial data

Symbol
GDTC on Nasdaq
Industry
Pharmaceutical Preparations
Location
#08 22 One Commonwealth, 1 Commonwealth Lane, Singapore
State of incorporation
Singapore
Fiscal year end
December 31
Former names
CytoMed Therapeutics Pte. Ltd. (to 11/30/2022)
Latest financial report
Q4 2023 - Apr 22, 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 11.5M shares +0.09%

Income Statement

Label TTM Value / Value Unit Change %
Research And Development Expense 1.2M USD +6.07%

Balance Sheet

Label TTM Value / Value Unit Change %
Goodwill 355 SGD 0%
Assets 9.38M USD +140%
Liabilities 853K USD -75.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Interest Expense 38.9K USD -58.4%